Contineum Therapeutics, Inc. Quarterly Common Stock, Value, Issued in USD from Q4 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Contineum Therapeutics, Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2023 to Q1 2024.
  • Contineum Therapeutics, Inc. Common Stock, Value, Issued for the quarter ending March 31, 2024 was $2K.
Common Stock, Value, Issued, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2K Mar 31, 2024 10-Q 2024-05-16
Q4 2023 $2K Dec 31, 2023 10-Q 2024-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.